Abstract With the purpose of facilitating clinical studies of this infrequent disease, an expert panel published research criteria for birdshot retinochoroiditis (RCBRC). The aim of our study was to investigate the sensitivity of the exclusion criteria of the RCBRC as applied to all patients seen in our center with a diagnosis of BRC. This was a single center retrospective study involving all patients with an ocular inflammatory disease seen at the Centre for Ophthalmic Specialized Care, Lausanne, Switzerland, between 1995 and 2012. The percentage of patients with a diagnosis of BRC was identified. The exclusion criteria of the RCBRC were applied to all patients and the percentage of patients with absence of keratic precipitates (KPs) and absence of posterior synechiae were calculated. Out of 1,504 new patients, 25 patients (1.66 %; 19 female, 6 male) were diagnosed with BRC and 19 patients had sufficient data to be included in the study (1.26 %, 13 female). All patients were positive for HLA-A29 testing. The sensitivity of the RCBRC with respect to the exclusion criteria applied to our patient cohort was 84.2 % due to the exclusion of three patients showing KPs. Our study supports the motion to re-evaluate the RCBRC, since granulomatous KPs can be present and are more frequent than previously estimated and stringent application of the criteria would lead to a substantial loss of study patients.
Introduction
Birdshot retinochoroiditis (BRC), described in 1980 by Ryan and Maumenee [1] , is a bilateral retinochoroidal inflammatory disease without any known systemic involvement. It is a rare disease affecting mainly Caucasian patients. It has been suggested that this predilection is due to a higher prevalence of HLA-A29. The proportion of BRC patients in European and North American uveitis series is 0.6-1.5 % of uveitis cases [2] [3] [4] [5] [6] . Typically, BRC affects age groups from 30-70 years with a median age around 50 years and with a strong gender predilection for women with a F/M ratio of 3/2 [7] .
Histopathology has revealed that the choroidal stroma is one site of inflammation, while the choriocapillaris and the pigment epithelium are intact [8] . The second independent site of inflammation is the retina, showing a massive vasculitis at the onset of the disease [8] . The latter histopathological investigation as well as a recent report did not identify granulomatous histological features [9] .
With the purpose of facilitating clinical studies of this infrequent disease, an expert panel published research criteria for BRC (RCBRC) as a consensus statement in 2006 [10] . Beside the mandatory bilaterality, typical signs for BRC like the presence of at least three peripapillary 'birdshot lesions' inferior or nasal to the optic disk in one eye need to be met. Furthermore, they proposed two exclusion criteria, both related to anterior chamber inflammation-keratic precipitates (KPs) and posterior synechiae (PS).
The aim of our retrospective study was to investigate the sensitivity of the exclusion criteria of the RCBRC as applied to all patients seen at our center with a diagnosis of BRC.
Methods
This was a single center retrospective study involving all patients with an ocular inflammatory disease seen at the Centre for Ophthalmic Specialized Care, Lausanne, Switzerland, between 1995 and 2012. All patients underwent complete routine work-up applied to patients with posterior uveitis. The study was performed in accordance with the Declaration of Helsinki.
The percentage of patients with a diagnosis of BRC was identified. Our diagnostic criteria for BRC included vitreitis and retinal vasculitis in either or both eyes, visual field anomalies in either or both eyes, stromal choroiditis as evidenced by indocyanine green angiography (ICGA) in both eyes and the presence of HLA-A29. An additional, non-obligatory diagnostic criterion indicating more advanced disease was the presence of rice-shaped depigmented 'birdshot lesions'. The exclusion criteria of the RCBRC were applied to all patients and the percentage of patients with absence of KPs and absence of PS were calculated.
Statistical analysis was performed using the statistics software GraphPad Prism (Version 5.02, GraphPad Software Inc., San Diego, C, USA).
Results
Out of 1,504 new patients with ocular inflammatory conditions seen between 1995 and 2012, 25 patients (1.66 %; 19 female, 6 male) were diagnosed with BRC and 19 patients had sufficient data to be included in the study (1.26 %, 13 female). All patients were Caucasian. Mean age at onset was 41 ± 4.4 years with a mean follow-up of 64 ± 38.6 months.
All patients were positive for HLA-A29 testing. Three out of 19 patients would not be allowed to be included in a BRC study (15.8 %), although they had all typical features of BRC. The sensitivity of the RCBRC with respect to their exclusion criterion as KP could be seen in her left eye that disappeared after a subtenon's injection of triamcinolone acetonide (40 mg). Vitreous inflammation was graded as 1.5 ? in the right eye and 1 ? in the left eye. On fundus examination, FA and ICGA, all features typical of BRC could be identified as in patient 12 (Fig. 2) . Patient 18 presented at the age of 52 years, with an onset of symptoms one year before. The patient had been refusing therapy for 3 years. At the time when two KPs were observed in his left eye (Fig. 2) , there was substantial anterior chamber inflammation present with flare values of 15.2 ph/ms in the right eye and 15.7 ph/ms in the left eye as well as a 2 ? vitreous infiltration. On fundus examination, FA and ICGA, all features typical for BRC could be identified as in the two previous patients (Fig. 3b) . As all other inflammatory parameters had also worsened, the patient finally accepted topical and systemic IST therapy which led to the disappearance of the KPs.
Discussion
We present here, to the best of our knowledge, the first report of a considerable proportion of patients with an obvious diagnosis of BRC, not fitting into the RCBRC due to the presence of KPs. Furthermore, these KPs were of the granulomatous type, bringing 'ipso facto' BRC into the group of granulomatous uveitis entities.
A more refined and prompt clinical appraisal is necessary, since BRC is an inflammatory condition which, if not treated early, has a deleterious prognosis regarding visual function in a large proportion of cases. This will be the result of further clinical research, needing sound international elaborated and accessible diagnostic criteria for a global audience [10] . However, these criteria must be phrased with caution since exclusion criteria will diminish the already sparse cohorts of patients. The RCBRC report does not state why they chose the absence of KPs as one of the 'sine qua non' criteria for the diagnosis of BRC. The reason why granulomatous KPs are rare is because anterior segment inflammation is very scarce with low flare values not prone to produce anterior inflammatory signs such as KPs [11] . We found three patients out of 19 showing granulomatous KPs (Fig. 3a) , all with the classical fundus appearance, FA signs and ICGA features of BRC (Figs. 1, 2, and 3b) . Two patients each presented one single granulomatous KP in one eye and the third patient showed two KPs in one eye. There was a tendency in all patients to have higher anterior chamber flare levels than the other patients of the cohort.
Our three patients with KPs presented with characteristic fundus, ICGA and FA findings of BRC and were all HLA-A29-positive, excluding other possible diagnoses.
Uveitis, as proposed by Woods in 1961, is classically divided into the two main groups-non-granulomatous and granulomatous uveitis [12] . It is a helpful subdivision in the appraisal of uveitis cases, as it substantially helps to orient investigations for the establishment of diagnosis [12] . This terminology is purely based on clinical signs of inflammation in the anterior segment and in particular on the type of KPs on the endothelium. Non-granulomatous uveitis is characterized by KPs appearing as dust on the endothelium and includes among others, Behçet's uveitis and HLA-B27-related uveitis [13, 14] . All uveitis cases showing KPs that can be individualized should be included in the group of granulomatous uveitis [15] . The aspect of granulomatous KPs goes from micro-granulomatous KPs such as in Fuchs' uveitis to large 'mutton-fat' KPs found in ocular sarcoidosis or tuberculosis [16, 17] . This terminology is in fact a misnomer as it uses a histological terminology to design clinical characteristics and presentations. Similarly when we talk of retinal vasculitis in a clinical setting this is also a misnomer as it uses a histological term, vasculitis, to describe clinical findings of vascular sheathing on fundoscopy or leaking on fluorescein angiography. The group of granulomatous diseases includes both histological granulomatous conditions such as ocular sarcoidosis or ocular tuberculosis and histological non-granulomatous conditions [18] . For Vogt-Koyanagi-Harada (VKH) disease non-granulomatous histological characteristics as well as granulomatous features were described depending on the evolutionary stage [19] . Unlike VKH disease, histological data for BRC are still scarce and histological findings were described as non-granulomatous in two cases reported to date [9, 12] . For the clinician it is important to understand that the clinical terms of granulomatous and non-granulomatous are not based on histological criteria but on clinical signs that go back the 1960s and allow a clinically meaningful subclassification of uveitis [12] .
In conclusion, the presented study supports our motion to re-evaluate the RCBRC, since KPs can clearly be found, are granulomatous, and are more frequent than previously anticipated. Stringent application of the criteria would lead to a loss of perfectly eligible cases. Furthermore, this study provides evidence that BRC is a granulomatous disease and should be classified as such.
